Search - tctmd.com

Displaying 501 - 520 of 1063

Sort: Relevancy | Date

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Bariatric Surgery: Cardiometabolic Benefits Down, but Not Out, at 5 Years

Michael O'Riordan

January 18, 2018

News Daily News

Prolonged DAPT Does Not Increase Mortality, Cancer Risk: More Evidence

L.A. McKeown

January 12, 2018

News Industry News

Positive Five-Year Data Published for MiStent in EuroIntervention

January 12, 2018

News Daily News

Further Calls to Update Guidelines for PFO Closure in Stroke Prevention

Yael L. Maxwell

January 08, 2018

News Daily News

Sex Differences Diminish With Third-Generation TAVR Device

L.A. McKeown

January 05, 2018

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Shelley Wood

January 05, 2018

STEMI Patients With Multivessel Disease Best Served by a Single Procedure: Meta-analysis

News Daily News

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

Caitlin E. Cox

December 15, 2017

News Daily News

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Caitlin E. Cox

December 12, 2017

News Daily News

Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial

L.A. McKeown

December 05, 2017

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

News Conference News AHA 2017

RE-DUAL PCI Findings Consistent Across Key Subgroups

Todd Neale

November 16, 2017

News Conference News AHA 2017

Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY

Michael O'Riordan

November 16, 2017

News Conference News AHA 2017

Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma

Todd Neale

November 15, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

Big BP Reductions When DASH Diet Combined With Low Sodium Intake

Michael O'Riordan

November 12, 2017

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

News Opinion Off Script TCT 2017

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Kwan S. Lee

November 01, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

Advertisement

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Bariatric Surgery: Cardiometabolic Benefits Down, but Not Out, at 5 Years

Prolonged DAPT Does Not Increase Mortality, Cancer Risk: More Evidence

Positive Five-Year Data Published for MiStent in EuroIntervention

Further Calls to Update Guidelines for PFO Closure in Stroke Prevention

Sex Differences Diminish With Third-Generation TAVR Device

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

RE-DUAL PCI Findings Consistent Across Key Subgroups

Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY

Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Big BP Reductions When DASH Diet Combined With Low Sodium Intake

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Live From Denver: TCT 2017, Day Four

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content